UK Department of Health awards vaccination contract to GSK ahead Sanofi

22 June 2008

The UK Department of Health has awarded a lucrative three-year contract for the cervical-cancer vaccination of school-age girls across Britain (Marketletter November 5, 2007) to the domestic company GlaxoSmithKline, ahead of rival Sanofi Pasteur MSD, a joint venture of French-based Sanofi-Aventis and the USA's Merck & Co. Sanofi's Gardasil lost out to GSK's Cervarix despite advice last year from a panel of scientific advisors to the DoH that the former guarded against a wider range of human papillomavirus types and was therefore the better candidate unless the latter drug was significantly cheaper. Both drugs have a formal list price of around L240 ($471) for a three-dose course. According to the partnership, Gardasil has a 90% market share in Europe, and 95% worldwide.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight